Abstract | BACKGROUND: METHODS: Twenty G-AgP patients and 20 periodontally healthy individuals were included. G-AgP patients received scaling and root planning (SRP), per quadrant at a 1-week-interval, performed with ultrasonic and periodontal hand instruments. GCF samples were collected and clinical periodontal parameters including probing depth, clinical attachment level, gingival index and plaque index were recorded at baseline, 1 and 3 months after treatment. Biomarker levels in GCF were analyzed by ELISA. RESULTS: At baseline all clinical parameters and GCF HIF-1α, VEGF, and TNF-α levels were significantly higher in G-AgP patients compared to healthy control (P < 0.05). All clinical parameters improved over the 3-month-period in G-AgP patients (P < 0.05). GCF HIF-1α levels in G-AgP reduced at 1 and 3 months post-treatment, however, this did not reach to statistical significance (P > 0.05). GCF VEGF and TNF-α levels remained unchanged throughout the study period (P > 0.05). CONCLUSIONS: Within the limitations of the present study, although HIF-1α seems to possess a potential diagnostic value for G-AgP, it might not be a proper predictor of clinically favorable treatment outcome. SRP plus different adjunctive therapies could provide better information about the prognostic role of hypoxia-inducible angiogenic pathway in G-AgP.
|
Authors | Beral Afacan, Zeynep Pinar Keleş Yücel, Çiğdem Paşali, Harika Atmaca İlhan, Timur Köse, Gülnur Emingil |
Journal | Journal of periodontology
(J Periodontol)
Vol. 91
Issue 11
Pg. 1495-1502
(11 2020)
ISSN: 1943-3670 [Electronic] United States |
PMID | 32246842
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2020 The Authors. Journal of Periodontology published by Wiley Periodicals, Inc. on behalf of American Academy of Periodontology. |
Chemical References |
- Tumor Necrosis Factor-alpha
- Vascular Endothelial Growth Factor A
|
Topics |
- Aggressive Periodontitis
(therapy)
- Dental Scaling
- Gingival Crevicular Fluid
(chemistry)
- Humans
- Hypoxia
- Tumor Necrosis Factor-alpha
(analysis)
- Vascular Endothelial Growth Factor A
|